公开(公告)号：US20180368460A1

公开(公告)日：2018-12-27

申请号：US16062598

申请日：2016-12-15

Applicant: GLYCOM A/S

Inventor： Bruce MCCONNELL ,  Louise Kristine VIGNÆS

IPC: A23L33/00

Abstract: A synthetic mixture of human milk oligosaccharides (HMOs) consisting essentially of lacto-N-neotetraose (LNnT), lacto-N-tetraose (LNT), 2′-fucosyllactose (2′FL), 3′-O-sialyllactose (3′-SL), 6′-O-sialyllactose (6′-SL) either difucosyllactose (DFL) or 3-fucosyllactose (3-FL), preferably DFL, and optionally lactose. Said synthetic composition is useful for: treating or preventing viral and/or bacterial infection in a non-infant human; modulating the microbiota of a non-infant human; and/or improving the cognitive function of a non-infant human and as a pharmaceutical or nutritional composition.

公开(公告)号：US20240407419A1

公开(公告)日：2024-12-12

申请号：US18808271

申请日：2024-08-19

Applicant: GLYCOM A/S

Inventor： Bruce MCCONNELL ,  Louise Kristine VIGNÆS

IPC: A23L33/00 ,  A23L33/12 ,  A23L33/135 ,  A23L33/19 ,  A23L33/195 ,  A61K31/702 ,  A61P31/04 ,  A61P31/12

Abstract: The invention relates to a mixture of human milk oligosaccharides that consists essentially of: LNnT, LNT, 2′-FL, 3′-SL, 6′-SL, either DFL or 3-FL, preferably DFL, useful for preventing and/or treating viral and/or bacterial infections in a non-infant human.

公开(公告)号：US20230000127A1

公开(公告)日：2023-01-05

申请号：US17929905

申请日：2022-09-06

Applicant: GLYCOM A/S

Inventor： Bruce MCCONNELL ,  Louise Kristine VIGNÆS

IPC: A23L33/00 ,  A61P31/04 ,  A23L33/135 ,  A61K31/702 ,  A61P31/12 ,  A23L33/195 ,  A23L33/12 ,  A23L33/19

Abstract: A synthetic mixture of human milk oligosaccharides (HMOs) consisting essentially of lacto -N-neotetraose (LNnT), lacto-N-tetraose (LNT), 2′-fucosyllactose (2′FL), 3′-O-sialyllactose (3′-SL), 6′-O-sialyllactose (6′-SL) either difucosyllactose (DFL) or 3-fucosyllactose (3-FL), preferably DFL, and optionally lactose. Said synthetic composition is useful for: treating or pre-venting viral and/or bacterial infection in a non-infant human; modulating the microbiota of a non-infant human; and/or improving the cognitive function of a non-infant human and as a pharmaceutical or nutritional composition.